Compare · BXS vs PBIO
BXS vs PBIO
Side-by-side comparison of BancorpSouth Bank (BXS) and Pressure BioSciences, Inc. (PBIO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BXS and PBIO operate in n/a (n/a), so they compete in similar markets.
- BXS carries a market cap of $3.12B.
- BXS has more recent analyst coverage (2 ratings vs 0 for PBIO).
BancorpSouth Bank
BancorpSouth Bank provides commercial banking and financial services to individuals and small-to-medium size businesses. The company operates through Banking Services Group, Mortgage, Insurance Agencies, Wealth Management, and General Corporate and Other segments. It accepts various deposit products, including interest and noninterest bearing demand deposits, and saving and other time deposits. The company also provides commercial loans, including term loans, lines of credit, equipment and receivable financing, and agricultural loans; a range of short-to-medium term secured and unsecured commercial loans to businesses for working capital, business expansion, and the purchase of equipment and machinery; and construction loans to real estate developers for the acquisition, development, and construction of residential subdivisions. In addition, it offers fixed and adjustable rate residential mortgage loans secured by owner-occupied property; construction loans; second mortgage loans; and home equity lines of credit, as well as non-residential consumer loans that consist of automobile, recreation vehicle, boat, personal, and deposit account secured loans, as well as issues credit cards. Further, the company operates as an agent for the sale of commercial lines of insurance; and offers a line of property and casualty, life, health, and employee benefits products and services. Additionally, it provides credit related products, trust and investment management, asset management, retirement and savings solutions, and estate planning and annuity products. As of March 4, 2021, the company operated through 305 full-service branch locations, as well mortgage, insurance, and loan production offices in Alabama, Arkansas, Florida, Louisiana, Mississippi, Missouri, Tennessee, and Texas; and an insurance location in Illinois. The company was formerly known as BancorpSouth, Inc. and changed its name to BancorpSouth Bank in October 2017. BancorpSouth Bank was founded in 1876 and is headquartered in Tupelo, Mississippi.
Pressure BioSciences, Inc.
Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the Americas, Europe, Asia, Africa, and Australia. Its pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. The company offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and The Shredder SG3. It also distributes cell disruption equipment, parts, and consumables. In addition, the company offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. It serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. Pressure BioSciences, Inc. has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was incorporated in 1978 and is based in South Easton, Massachusetts.
Latest BXS
- SEC Form 13F-HR filed by BancorpSouth Bank
- BancorpSouth Bank and Cadence Bancorporation Complete Their Merger
- BancorpSouth Bank Declares Quarterly Common and Preferred Dividend
- BancorpSouth upgraded by Keefe Bruyette with a new price target
- Avid Bioservices Set to Join S&P SmallCap 600
- BancorpSouth Announces Third Quarter 2021 Results
- BancorpSouth Bank and Cadence Bancorporation Receive Final Regulatory Approval for Merger
- The First Agrees to Purchase Seven Cadence Bank Branches
- BancorpSouth Bank upgraded by Raymond James with a new price target
- BancorpSouth Adds Six New HOPE Inside Locations and Commits Nearly $1.5 Million to Operation HOPE for Financial Literacy Programs
Latest PBIO
- SEC Form 10-Q filed by Pressure BioSciences, Inc.
- Director Peterson Jeffrey N acquired $1,670 worth of shares (59,652 units at $0.03), increasing direct ownership by 72% to 142,084 units (SEC Form 4)
- Director Urdea Michael S acquired $404 worth of shares (14,429 units at $0.03), increasing direct ownership by 44% to 47,588 units (SEC Form 4)
- President, CEO Schumacher Richard T acquired $641 worth of shares (22,878 units at $0.03), increasing direct ownership by 38% to 82,967 units (SEC Form 4)
- Director Lazarev Alexander V acquired $528 worth of shares (18,863 units at $0.03), increasing direct ownership by 102% to 37,400 units (SEC Form 4)
- SEC Form 10-Q filed by Pressure BioSciences, Inc.
- SEC Form NT 10-Q filed by Pressure BioSciences, Inc.
- Pressure BioSciences, Inc. filed SEC Form 8-K: Other Events
- Pressure BioSciences, Inc. filed SEC Form 8-K: Leadership Update
- Pressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ET